Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Head of Commercial content
USA
Citeline, Scrip, Biomedtracker, Datamonitor Healthcare
By Mary Jo Laffler 29 May 2018
Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.
Topic Clinical trials
Scrip
By Mary Jo Laffler 30 May 2017
Merck's PD-1 inhibitor holds the first cancer indication based on biomarkers rather than tumor location. The most significant market will be colorectal cancer.
Topic Drug approval
Scrip
By Mary Jo Laffler 14 Mar 2017
Amgen has already reported the positive topline result of its FOURIER cardiovascular outcomes trial for its PCSK9 inhibitor Repatha, but analysts from Datamonitor Healthcare and Biomedtracker lay out the reasons to check out the full results and other highlights at the upcoming American College of Cardiology meeting
Scrip
By Mary Jo Laffler 14 Dec 2016
Using Pharmapremia data, we analyze performance metrics for a select group of leading cancer companies to see where the sticking points are and who is winning at industry’s most important race.
Topic Cancer Strategy Company analysis
Scrip
16 Oct 2018
Scrip
08 Jun 2018
Scrip
28 Aug 2017
Scrip
15 Jun 2017
Pink Sheet
05 Jun 2017
Scrip
05 Jun 2017
Scrip
25 May 2017
Medtech Insight
24 May 2017
Pink Sheet
23 May 2017
Scrip
29 Apr 2017
Pink Sheet
19 Mar 2017
Pink Sheet
19 Mar 2017
Scrip
18 Mar 2017
Scrip
14 Mar 2017
Scrip
13 Feb 2017
